TUBERCULOSIS TRANSMISSION IN A SOUTH AFRICAN PRISON Robin Wood Desmond Tutu HIV Centre Institute of Infectious Disease & Molecular Medicine University.

Slides:



Advertisements
Similar presentations
TB 101 “Basic Facts on Tuberculosis”
Advertisements

Implementing a TB-Control Program in Prisons: The Basics Dr. Mayra Arias.
Purpose of 2005 Guidelines Update and replace 1994 Mycobacterium tuberculosis infection control (IC) guidelines Further reduce threat to health-care workers.
Improving diagnosis TB laboratory strengthening.
Endemic or Outbreak? Differentiating recent transmission of an historic tuberculosis strain in New York City IUATLD-NAR 16 th Annual Meeting February 23-25,
M. Samarkos TUBERCULOSIS IN GREECE. INTRODUCTION.
Unit 6.5. Facility design, renovation, and use TB Infection Control Training for Managers at National and Subnational Level.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
Anders Chen, MD Internal Medicine R3 4/5/2011.  TB infection control (TB IC): Background  WHO Policy recommendations  Literature review  Practical.
GAP Report 2014 Prisoners People left behind: Prisoners Link with the pdf, Prisoners.
Mary Foote MD, MPH 1 Infectious Disease Fellow Anne Spaulding MD, MPH 1,2 1 Emory University Schools of Medicine and 2 Public Health Atlanta, Georgia Georgia.
Technical Advisory Group meeting, WHO/WPRO
West Virginia’s Tuberculosis Control Program Hx and Epi MissionTransmissionRequirements Channels of Communication.
Tuberculosis in the UK 2013 report
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
Reduced treatment delays for drug-resistant TB/HIV co-infected patients with decentralised care and rapid Xpert MTB/Rif test in Khayelitsha, South Africa.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
TUBERCULOSIS * Prevention * Treatment, and * Challenges.
Epidemiology.
A decentralized model of care for drug-resistant tuberculosis in a high HIV prevalence setting Cheryl McDermid, Helen Cox, Simiso Sokhela, Gilles van Cutsem,
The Research and Development Goals of the Global Plan to Stop TB Marcos Espinal Executive Secretary.
Epidemiology of tuberculosis. Peymane Adab, Richard Fielding, Susana Castan.
Tuberculosis What is tuberculosis?.
Ecdc.europa.eu Tommi Asikainen, Tubingen, 22 October 2008 European Centre for Disease Prevention and Control FUTURE DISEASE CHALLENGES IN EUROPE – where.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Missed opportunities to diagnose TB and HIV Co-infection in HIV workplace program Dr Fred Mugyenyi Asiimwe Medical Director, ALAFA.
Module 2 - Epidemiology of Tuberculosis
Update of the Global Plan to Stop TB TB/HIV Working Group Meeting Geneva, November 2009 Christian Lienhardt.
Universal access to TB care what is the challenge, what policy, what is being implemented Cancun 3 December 2009 Léopold BLANC and TBS team TBS/STB/WHO.
1 [INSERT SPEAKER NAME DATE & LOCATION HERE] Ethics of Tuberculosis Prevention, Care and Control MODULE 2: BACKGROUND ON TUBERCULOSIS Insert country/ministry.
Proposed Post-2015 Global Tuberculosis Strategy and Targets Dr Mario Raviglione Director, Global TB Programme World Health Organization, Geneva, Switzerland.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Recent Epidemiologic Situations of TB in Myanmar -Preliminary Review of Data from routine TB surveillance focusing on Case Finding- 9 May 2014, Nay Pyi.
CDC Guidelines for Use of QuantiFERON ® -TB Gold Test Philip LoBue, MD Centers for Disease Control and Prevention Division of Tuberculosis Elimination.
Washington D.C., USA, July 2012www.aids2012.org Implementing Xpert ® MTB/RIF in Rural Zimbabwe Impact on diagnosis of smear-negative TB and time-
Improving Tuberculosis Infection Control
© Annual number of new reported TB cases. Data from WHO.[46][46]
Early TB case detection in pre-trial detention centers (SIZOs) and prison colonies in Ukraine 46 th Union World Conference on Lung Health Cape Town, South.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
Challenges of Intensified TB case finding among PLHIV : Kenyan experience Dr. J. Sitienei Ministry of Health Kenya.
Screening – a discussion in clinical preventive medicine Galit M Sacajiu MD MPH.
The 16 th International Conference on AIDS & STIs in Africa, Addis Ababa Trends in HIV Seroprevalence among clients with newly diagnosed tuberculosis in.
TB in Yorkshire and the Humber Dr Simon Padfield 14 th Sept 2007.
Measures to Decrease TB Prevalence in the Barents Region Andrey O. Maryandyshev Elena I. Nikishova Dmitry V. Perkhin.
Rauni Ruohonen FILHA Priorities of TB control in penitentiary care.
National TB Infection Control Seminar S’celo S. Dlamini Director: Research, Information, Monitoring, Evaluation & Surveillance 12 th of August 2015 Integrating.
5 TH NATIONAL QUALITY IMPROVEMENT FORUM: KILIMANJARO HOTEL 2015: Theme: Contribution of quality improvement in attainment of health and social welfare.
DISCUSSION Demographic and Housing Status of the Respondents. Out of the 3456 respondents to the BES survey in TTS district, 93 TB cases were found and.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Increasing Tuberculosis Prevalence in South African Township Associated With Increasing HIV Prevalence Slideset on: Lawn SD, Bekker LG, Middelkoop K, Myer.
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
Prisons and TB in Europe
This is an archived document.
Novel approaches to TB infection control in private general hospitals in Georgia T Gabunia1, I Khonelidze, N Solomonia, T Merabishvili, M Makharadze,
The intersection between diabetes and tuberculosis: a perspective
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Pre-conference Meeting Report
TB Infection Control Actions needed at country level
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Knowledge gaps in formulating TB Control Policies for Prisons
TB Infection Control Actions needed at country level
Tolerability of Isoniazid Preventive therapy Among HIV infected Cohort in Nigeria Folajinmi Oluwasina Strategic Information Unit AIDS Healthcare Foundation,
Implementing a TB-Control Program in Prisons: The Basics
Introduction to public health surveillance
Collaborative TB/HIV activities in European Region
A Time of Commitments and Actions to accelerate action to End TB
Presentation transcript:

TUBERCULOSIS TRANSMISSION IN A SOUTH AFRICAN PRISON Robin Wood Desmond Tutu HIV Centre Institute of Infectious Disease & Molecular Medicine University of Cape Town

NEW YORK 1903 The average prison is no less than a tubercular death trap.. from forty to sixty per cent, of all the deaths in prison are due to tuberculosis and autopsies show that nearly all the prisoners have in some degree been infected!” Dr. J. B. Ransom, of Clinton Prison, New York

December 2010 | Volume 7 | Issue 12 | e The median estimated annual incidence rate ratio (IRR) for LTBI and TB were 26.4 (interquartile range [IQR]: 13.0–61.8) and 23.0 (IQR: 11.7–36.1), respectively. The median estimated fraction (PAF%) of tuberculosis in the general population attributable to the exposure in prisons for TB was 8.5% (IQR: 1.9%–17.9%) and 6.3% (IQR: 2.7%–17.2%) in high- and middle/low-income countries, respectively. These findings suggest that the risk of LTBI and TB is at least an order of magnitude higher in prisons than in the general population and that the within-prison spread of LTBI and TB is likely to substantially affect the incidence of LTBI and TB in the general population.

CURRENT WHO RECOMMENDATIONS The priority strategy must be the widespread implementation of the Stop TB Strategy, particularly addressing TB/HIV co-infection and MDR-TB, in the incarcerated population. Every prisoner should have unrestricted access to the correct diagnosis and treatment of TB. Delays in the detection and treatment of TB cases must be minimized to reduce further transmission of infection and pressures to self-treat TB. Unregulated, erratic treatment of TB in prisons should cease. Urgent action is needed to integrate prison and civilian TB services to ensure treatment completion for prisoners released during treatment. Measures to reduce overcrowding and to improve living conditions for all prisoners should be implemented to reduce transmission of TB

TB TRANSMISSION A.Quantity of exhaled air rebreathed B.Concentration of TB particles Infectious TB case Susceptible individual

Probability of TB infection Concentration of TB organisms Quantity of rebreathed air TB INFECTION RISK IN PRISONS No of TB cases Infectivity Period of infectivity=Δ Cell crowding Lock-up time Cell ventilation

Pollsmoor prison has 3,200 awaiting trial prisoners Space allocation: 1,4 m 2 per prisoner Lock-up time 23 hours per day SAMJ 2011;101(11):809-13

Fig. 1. The effect of prison cell overcrowding on TB transmission probabilities is plotted against time periods of infectiousness up to 180 days. They are shown for 3 levels of overcrowding; 250% approximates the current level cell occupancy; 100% represents implementation of current South African statutory minimum occupancy of 3.44 m2 of floor space per inmate,7-10 and 50% corresponds to international space recommendations. SAMJ 2011;101(11): CROWDING & TB TRANSMISSION Space allocation: 1,4 m 2 per prisoner WHO 5.4m 2 RSA 3.4m 2 Current 1.4m 2

Fig. 2. The effect of length of period of restriction in prison cell per day on TB transmission probabilities is plotted against time periods of infectiousness up to 180 days, shown for 3 time periods of cell occupancy during a 24-hour period; 23 hours per day, 12 hours per day and 8 hours per day. NB: 23 hours per day is the current period of restriction to cells in Pollsmoor prison. LOCK-UP TIME & TB TRANSMISSION SAMJ 2011;101(11):809-13

CELL VENTILATION

CELL VENTILATION & TB TRANSMISSION Fig. 3. The effect of increasing levels of cell ventilation on TB transmission probabilities is plotted against time periods of infectiousness up to 180 days. They are shown for 4 values of ventilation air change per hour (ACH): 1 ACH (current estimated cell ventilation), 3 ACH (minimal international recommendation), 8 ACH (moderately increased ventilation) and 12 ACH (the optimal level of ventilation recommended by WHO for health care set- tings). SAMJ 2011;101(11):809-13

COMBINED TB CONTROL MEASURES Fig. 2. The effect of length of period of restriction in prison cell per day on TB transmission probabilities is plotted against time periods of infectiousness up to 180 days, shown for 3 time periods of cell occupancy during a 24-hour period; 23 hours per day, 12 hours per day and 8 hours per day. NB: 23 hours per day is the current period of restriction to cells in Pollsmoor prison. SAMJ 2011;101(11):809-13

PRISON CELL CO 2 LEVELS > 5000ppm (SABS 1040) ASHRAE Standard ppm – CO2 concentration in occupied buildings should not exceed 1000ppm Building bulletin 101 (BB101) 1500ppm – UK standard for schools, average CO2 during day should not exceed 1500ppm EPA Taiwan 1000ppm and 600ppm – Type-1: Stores, theaters, restaurants, & libraries the 8hour average CO2 should not exceed 1000ppm – Type 2: Special areas e.g. schools, hospital, day care centers recommend 600ppm Regulatory CO 2 Exposure Limits

The average prison is no less than a tubercular death trap. Dr. J. B. Ransom 1903

TUBERCULOSIS CONTROL IN PRISONS Decrease TB disease prevalence – Effective TB case management – Active case finding at entry and subsequently – Rapid diagnostics Reduce overcrowding – Communal cells are a disaster! – Lock up times too long! Ventilation – Use appropriate building codes – Maintain cross cell air flow – Ventilation monitored by CO 2